Terms: = Skin cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL
3579 results:
1. A Comparative Analysis of Implant-sparing Plan
Onal C; Bozca R; Dolek Y; Elmali A; Guler OC
In Vivo; 2024; 38(3):1412-1420. PubMed ID: 38688603
[TBL] [Abstract] [Full Text] [Related]
2. Decoding dynamic interactions between EGFR-TKD and DAC through computational and experimental approaches: A novel breakthrough in lung melanoma treatment.
Meher RK; Mir SA; Singh K; Mukerjee N; Nayak B; Kumer A; Zughaibi TA; Khan MS; Tabrez S
J Cell Mol Med; 2024 May; 28(9):e18263. PubMed ID: 38685671
[TBL] [Abstract] [Full Text] [Related]
3. In Silico Transcriptomic Expression of MSR1 in Solid Tumors Is Associated with Responses to Anti-PD1 and Anti-CTLA4 Therapies.
Sanvicente A; Díaz-Tejeiro C; Nieto-Jiménez C; Paniagua-Herranz L; López Cade I; Balázs G; Moreno V; Pérez-Segura P; Calvo E; Ocaña A
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612803
[TBL] [Abstract] [Full Text] [Related]
4. Atmospheric occurrences and bioavailability health risk of PAHs and their derivatives surrounding a non-ferrous metal smelting plant.
Deng W; Wen M; Xiong J; Wang C; Huang J; Guo Z; Wang W; An T
J Hazard Mater; 2024 May; 470():134200. PubMed ID: 38593661
[TBL] [Abstract] [Full Text] [Related]
5. Assessment of Social Vulnerabilities of Care and Prognosis in Adult Ocular Melanomas in the US.
Mensah JA; Fei-Zhang DJ; Rossen JL; Rahmani B; Bentrem DJ; Stein JD; French DD
Ann Surg Oncol; 2024 May; 31(5):3302-3313. PubMed ID: 38418655
[TBL] [Abstract] [Full Text] [Related]
6. Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease.
Baumrin E; Shin DB; Mitra N; Pidala J; El Jurdi N; Lee SJ; Loren AW; Gelfand JM
JAMA Dermatol; 2024 Apr; 160(4):393-401. PubMed ID: 38416506
[TBL] [Abstract] [Full Text] [Related]
7. Immunogenicity of avelumab in patients with metastatic Merkel cell carcinoma or advanced urothelial carcinoma.
Hu P; Dai HI; Bourdage J; Zhou D; Trang K; Kowalski K; Bello C; Hibma J; Khandelwal A; Cowan K; Dong J; Venkatakrishnan K; Gao W
Clin Transl Sci; 2024 Mar; 17(3):e13730. PubMed ID: 38411318
[TBL] [Abstract] [Full Text] [Related]
8. Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial.
Bol KF; Schreibelt G; Bloemendal M; van Willigen WW; Hins-de Bree S; de Goede AL; de Boer AJ; Bos KJH; Duiveman-de Boer T; Olde Nordkamp MAM; van Oorschot TGM; Popelier CJ; Pots JM; Scharenborg NM; van de Rakt MWMM; de Ruiter V; van Meeteren WS; van Rossum MM; Croockewit SJ; Koeneman BJ; Creemers JHA; Wortel IMN; Angerer C; Brüning M; Petry K; Dzionek A; van der Veldt AA; van Grünhagen DJ; Werner JEM; Bonenkamp JJ; Haanen JBAG; Boers-Sonderen MJ; Koornstra RHT; Boomsma MF; Aarntzen EHJ; Gotthardt M; Nagarajah J; de Witte TJM; Figdor CG; de Wilt JHW; Textor J; de Groot JWB; Gerritsen WR; de Vries IJM
Nat Commun; 2024 Feb; 15(1):1632. PubMed ID: 38395969
[TBL] [Abstract] [Full Text] [Related]
9. TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors: Dose escalation and expansion part of a multicenter open-label phase I trial (SAKK 65/16).
Colombo I; Koster KL; Holer L; Haefliger S; Rabaglio M; Bastian S; Schwitter M; Eckhardt K; Hayoz S; Mc Laughlin AM; Kloft C; Klose M; Halbherr S; Baumgartner C; Sessa C; Stathis A; Hess D; Joerger M
Eur J Cancer; 2024 Apr; 201():113588. PubMed ID: 38377773
[TBL] [Abstract] [Full Text] [Related]
10. Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma: The ATOMIC-Meso Randomized Clinical Trial.
Szlosarek PW; Creelan BC; Sarkodie T; Nolan L; Taylor P; Olevsky O; Grosso F; Cortinovis D; Chitnis M; Roy A; Gilligan D; Kindler H; Papadatos-Pastos D; Ceresoli GL; Mansfield AS; Tsao A; O'Byrne KJ; Nowak AK; Steele J; Sheaff M; Shiu CF; Kuo CL; Johnston A; Bomalaski J; Zauderer MG; Fennell DA;
JAMA Oncol; 2024 Apr; 10(4):475-483. PubMed ID: 38358753
[TBL] [Abstract] [Full Text] [Related]
11. ARID2 mutations may relay a distinct subset of cutaneous melanoma patients with different outcomes.
Akinjiyan FA; Nassief G; Phillipps J; Adeyelu T; Elliott A; Abdulla F; Zhou AY; Souroullas G; Kim KB; Vanderwalde A; Park SJ; Ansstas G
Sci Rep; 2024 Feb; 14(1):3444. PubMed ID: 38341515
[TBL] [Abstract] [Full Text] [Related]
12. Relative predictive value of sociodemographic factors for chronic diseases among All of Us participants: a descriptive analysis.
Kunnath AJ; Sack DE; Wilkins CH
BMC Public Health; 2024 Feb; 24(1):405. PubMed ID: 38326799
[TBL] [Abstract] [Full Text] [Related]
13. Pan-cancer analyses of bromodomain containing 9 as a novel therapeutic target reveals its diagnostic, prognostic potential and biological mechanism in human tumours.
Chen Y; Gao Z; Mohd-Ibrahim I; Yang H; Wu L; Fu Y; Deng Y
Clin Transl Med; 2024 Feb; 14(2):e1543. PubMed ID: 38303608
[TBL] [Abstract] [Full Text] [Related]
14. skin cancer prevention in extreme sports: Intervention in a 24-h race.
Martínez AR; Pardal CV; Arjona JA; Ruiz FR; Molinero DD; Paulano MR; Subert A; Manzanedo JVG; Cambil Martín J; de Gálvez Aranda MV; López LJ; Sánchez NB; de Troya Martín M
Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):e12940. PubMed ID: 38288775
[TBL] [Abstract] [Full Text] [Related]
15. A comparative study on inhibition of lung cancer cells by nanoemulsion, nanoliposome, nanogold and their folic acid conjugates prepared with collagen peptides from Taiwan tilapia skin.
Inbaraj BS; Lai YW; Chen BH
Int J Biol Macromol; 2024 Mar; 261(Pt 1):129722. PubMed ID: 38280696
[TBL] [Abstract] [Full Text] [Related]
16. Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program.
King B; Soung J; Tziotzios C; Rudnicka L; Joly P; Gooderham M; Sinclair R; Mesinkovska NA; Paul C; Gong Y; Anway SD; Tran H; Wolk R; Zwillich SH; Lejeune A
Am J Clin Dermatol; 2024 Mar; 25(2):299-314. PubMed ID: 38263353
[TBL] [Abstract] [Full Text] [Related]
17. Racial Disparities in Mycosis Fungoides/Sézary Syndrome-A Single-Center Observational Study of 292 Patients.
Gandham AR; Geller S; Dusza SW; Kupper TS; Myskowski PL
Clin Lymphoma Myeloma Leuk; 2024 Apr; 24(4):e174-e180. PubMed ID: 38245472
[TBL] [Abstract] [Full Text] [Related]
18. Infant lung function and early skin barrier impairment in the development of asthma at age 3 years.
Färdig M; Hoyer A; Almqvist C; Bains KES; Carlsen KCL; Gudmundsdóttir HK; Granum B; Haugen GN; Hedlin G; Jonassen CM; Konradsen JR; Lie A; Rehbinder EM; Skjerven HO; Staff AC; Vettukattil R; Söderhäll C; Nordlund B
Allergy; 2024 Mar; 79(3):667-678. PubMed ID: 38239099
[TBL] [Abstract] [Full Text] [Related]
19. Multifaceted approach toward mapping out the anticancer properties of small molecules via in vitro evaluation on melanoma and nonmelanoma skin cancer cells, and in silico target fishing.
Boateng ST; Roy T; Agbo ME; Mahmud MA; Banang-Mbeumi S; Chamcheu RN; Yadav RK; Bramwell M; Pham LK; Dang DD; Jackson KE; Nagalo BM; Hill RA; Efimova T; Fotie J; Chamcheu JC
Chem Biol Drug Des; 2024 Jan; 103(1):e14418. PubMed ID: 38230791
[TBL] [Abstract] [Full Text] [Related]
20. Minimal clinically important difference in the World Health Organization Quality of Life Brief (WHOQOL-BREF) for adults with neurofibromatosis.
Pietrzykowski MO; Vranceanu AM; Macklin EA; Mace RA
Qual Life Res; 2024 May; 33(5):1233-1240. PubMed ID: 38214851
[TBL] [Abstract] [Full Text] [Related]
[Next]